Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastases

Abstract

BackgroundThe positive role of CD8+ tumor-infiltrating lymphocytes (TIL) in patients with colorectal cancer (CRC) has been well described but the prognostic value of CD4 T cell subsets remained to be investigated. In this study, we expanded TIL from surgically resected liver metastases of patients with CRC and characterized the phenotype and the prognostic value of expanded-CD4 T cells.MethodsLiver metastases were surgically resected from 23 patients with CRC. Tumors were enzymatically digested and cultured in high dose of interleukin-2 for up to 5 weeks. T cell phenotype and reactivity of cultured-T cells were measured by flow cytometry and correlated with patients’ clinical outcomes.ResultsWe successfully expanded 21 over 23 TIL from liver metastases of patients with CRC. Interestingly, we distinguished two subsets of expanded T cells based on T cell immunoglobulin mucin domain-containing protein 3 (TIM-3) expression. Medians fold expansion of expanded T cells after rapid expansion protocol was higher in CD3+TIM-3low cultures. In an attempt to investigate the correlation between the phenotype of expanded CD4 T cells and clinical outcomes, we observed on one hand that the level of Tregs in culture as well as the expression of both PD1 and TIM-3 by expanded T cells was not correlated to the clinical outcomes. Interestingly, on the other hand, cultures containing high levels of Th17 cells were associated with a poor prognosis (p=0.0007).ConclusionsOur data confirmed the presence of Th17 cells in expanded T cells from liver metastases. Among CD4 T cell characteristics investigated, TIM-3 but not programmed cell death protein 1 predicted the expansion capacity of TIL while only the Th17 phenotype showed correlation with patients’ survival, suggesting a particular role of this T cell subset in CRC immune contexture.Trial registration numberNCT02817178.

A cellular census of human peripheral immune cells identifies novel cell states in lung diseases

“…39 Memory T cells induction or maintenance could be a novel therapy strategy. 40,41 We found the exhaustion of CD4 + TEM in patients with acute pneumonia accompanied with a decrease of CCR7 + CD45RA + naïve T cells (CD38 + HLA-DR + ). The TEM-increased immune states existed in patients with stable and acute asthma.…”

The Colorectal Cancer Tumor Microenvironment and Its Impact on Liver and Lung Metastasis

“…Helper T Cells in CRLM and CRPM Kroemer et al [90] demonstrated that the presence of expanded T H 17 CD4+ T cells in resected CRLM was associated with poor prognosis. At the tumor site, while CD4+ T cells may be the most frequently encountered T-cell population, their ability to proliferate in response to tumor antigens after DC-mediated pulsing was significantly diminished [91].…”

Store-Operated Ca2+ Entry Is Up-Regulated in Tumour-Infiltrating Lymphocytes from Metastatic Colorectal Cancer Patients

“…CD8+ cytotoxic T lymphocytes (CTLs), which are induced to recognise specific tumour-associated antigens (TAAs), have also been shown to be effective against types of solid tumours [ 8 , 9 , 10 , 11 , 12 ]. The short-term expansion of naturally occurring tumour-reactive CD8+ TILs from the liver metastases of CRC patients has recently been described by two independent groups [ 13 , 14 ]. However, it is still unclear whether these TILs could be employed to effectively target metastatic CRC (mCRC) [ 15 ].…”